ECHA’s official Registry of restriction intentions until outcome shows the EU-wide PFAS REACH restriction entry in 'Opinion development' status, with the registry reflecting a latest update date of 16-Apr-2026. This is not an adopted restriction, but it is an authoritative process/status signal that the dossier has progressed into the committee opinion-development phase and is useful for compliance teams monitoring expected timelines and upcoming milestones under the proposed universal PFAS restriction.
ECHA opened a 60-day stakeholder consultation on SEAC’s draft opinion related to the proposed EU-wide REACH restriction on PFAS (universal PFAS proposal). ECHA communications also confirm RAC has adopted its opinion on the restriction proposal and that the committees support an EU-wide restriction with targeted derogations and risk-management measures for derogated uses. Compliance teams should use the open consultation window to submit technical and socioeconomic evidence, especially regarding use essentiality, alternatives, transition timelines, and emission minimisation/management measures that could become conditions of any future restriction.
ECHA’s PFAS hot-topics page highlights an upcoming compliance horizon: restrictions for undecafluorohexanoic acid (PFHxA), its salts and related substances will start applying in April 2026 in the EU/EEA. Compliance teams should use this as a planning trigger to review product portfolios and supply chains for PFHxA-related substances and ensure readiness for EU restriction applicability, including substitution, supplier declarations, and potential reformulation timelines. (The research text does not provide a specific day in April 2026, so no implementation date is recorded.)
ECHA announced procedural next steps for the proposed EU-wide REACH restriction on PFAS, stating it plans to launch a 60-day public consultation on SEAC’s draft opinion after the committee meeting in March 2026 (i.e., planned for spring 2026). Compliance teams should anticipate an upcoming consultation window and prepare to submit evidence on uses, socio-economic impacts, and substitution timelines relevant to their PFAS-related products and supply chains.
ECHA’s PFAS hot-topics page indicates that undecafluorohexanoic acid (PFHxA), its salts and related substances are subject to REACH restrictions starting in April 2026 (referenced as an already adopted restriction with a future start date). Compliance teams supplying or using PFHxA-related substances in the EU/EEA should confirm applicability, assess product/mixture impacts, and plan substitution or supply-chain controls ahead of the April 2026 restriction start date; however, the specific day in April is not provided in the extracted research text.
On 4 February 2026, ECHA updated the REACH Candidate List of Substances of Very High Concern (SVHCs) by adding two new entries: (1) n-hexane (EC 203-777-6; CAS 110-54-3), identified under REACH Article 57(f) (human health) due to specific target organ toxicity after repeated exposure; and (2) 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (group entry including bisphenol AF and salts), identified under REACH Article 57(c) (toxic for reproduction). The Candidate List total increased to 253 entries. Compliance teams should assess impacts on downstream REACH SVHC obligations triggered by Candidate List inclusion, including Article 33 communication obligations for SVHCs in articles above 0.1% w/w, Article 7(2) notification duties for SVHCs in articles (within six months of inclusion date as described by ECHA), and ensuring SDS are updated when supplying the substances as such or in mixtures. The official Candidate List table serves as the authoritative record of inclusion and entry details.
ECHA’s Registry of SVHC intentions until outcome shows an update (last updated 4 February 2026), reflecting the current status of SVHC identification intentions (e.g., intentions marked withdrawn or progressed). This is SVHC-relevant operational guidance for compliance and regulatory intelligence teams because it provides an official forward-looking view of substances that may be proposed for SVHC identification, supporting proactive supply-chain risk screening and substance substitution planning.
ECHA published a notice announcing the next step in the EU-wide PFAS restriction process under REACH: a planned 60-day consultation on SEAC’s draft opinion (socio-economic impacts and alternatives). The consultation is expected to start after SEAC’s March 2026 meeting, run for 60 days, and be conducted via a structured survey (no attachments). This is a key stakeholder engagement milestone for companies and downstream users to prepare socio-economic and alternatives information for the restriction evaluation.
ECHA’s Single Programming Document 2026–2028 includes an official planning milestone indicating ECHA aims to finalise the opinion-making process in 2026 for the broad (universal) PFAS restriction proposal under REACH. This is not a legal restriction yet, but it is a credible timeline signal for compliance teams tracking expected EU-wide PFAS controls and potential future substitution/phase-out planning.
ECHA reported progress by its Committee for Risk Assessment (RAC) and Committee for Socio-Economic Analysis (SEAC) in evaluating the proposed EU-wide PFAS restriction under REACH. ECHA indicated RAC is expected to adopt its opinion in March 2026 and SEAC is expected to agree a draft opinion to be followed by a stakeholder consultation. Compliance teams should treat this as a timeline signal for when the restriction proposal could move closer to a Commission decision and begin preparing supply-chain use information and substitution planning for potentially affected PFAS uses.
ECHA reported progress by the REACH committees (RAC and SEAC) on the proposed EU-wide PFAS restriction, indicating that RAC was expected to adopt its opinion in March 2026 and that SEAC would move toward agreeing a draft opinion for subsequent consultation. For compliance teams, this is a procedural milestone indicating when the proposal may advance to the next stage (consultation and eventual Commission decision), supporting planning for potential future PFAS restrictions across multiple sectors.
ECHA reported (via its December 2025 RAC/SEAC meeting highlights) continued committee evaluation of the proposed EU-wide REACH restriction covering PFAS. This is a process milestone for stakeholders tracking the restriction: it signals the committees’ expected timing for adoption of opinions (including an expected RAC opinion in 2026 as stated in the ECHA update), which will inform later European Commission decision-making and any eventual compliance timelines.
ECHA published consultation support materials for stakeholders preparing to respond to the forthcoming consultation on SEAC’s draft opinion regarding the proposed EU-wide REACH restriction on PFAS. The guidance explains how respondents should provide information during the planned consultation and is accompanied by a PFAS use-mapping annex to support structured submissions. Compliance teams should use these materials to prepare socio-economic and use-specific input for the upcoming restriction evaluation process.
ECHA published a “current status/state of play” document for the proposed EU-wide PFAS restriction under REACH, outlining committee evaluation milestones. The document indicates a target for RAC to adopt its opinion and for SEAC to agree its draft opinion in March 2026, after which a 60-day public consultation on SEAC’s draft opinion is expected, with ECHA’s final opinion to follow later in 2026. Compliance teams tracking a potential broad PFAS restriction should use this schedule to plan for likely spring 2026 consultation participation and internal impact assessments, while noting this is not yet a binding restriction.
ECHA summarized December 2025 RAC and SEAC meeting highlights indicating continued committee examination of the proposed EU-wide PFAS restriction, including horizontal issues such as potential concentration limits and PFAS management/implementation considerations. For compliance teams, this provides an official status signal on how the restriction proposal is being refined (e.g., potential parameters/limits), which can affect future compliance planning for PFAS uses in products and processes.
ECHA published a PFAS restriction evaluation status document describing the anticipated REACH restriction process timeline for the broad PFAS proposal. The document states that RAC is expected to adopt its opinion in March 2026 and SEAC is expected to agree its draft opinion in March 2026, followed by a 60-day consultation on SEAC’s draft opinion and delivery of ECHA’s final opinion to the European Commission later in 2026. This is not a binding restriction change, but it is compliance-relevant because it signals when restrictions may crystallize and when stakeholders may be asked to respond to consultations.
ECHA reported (via RAC/SEAC meeting highlights) continued evaluation of the proposed EU-wide PFAS restriction under REACH and communicated expected committee milestones, including RAC adoption of its opinion anticipated in March 2026, with SEAC draft opinion development and subsequent consultation to follow. This update is relevant for compliance planning and preparing for forthcoming committee opinions and stakeholder consultation steps, but it is not a final restriction or binding change yet.
On 18 November 2025, ECHA issued a recommendation to the European Commission to add four SVHCs to the REACH Authorisation List (Annex XIV). While this is not itself a Candidate List change, it is directly SVHC-relevant because Annex XIV inclusion is a subsequent regulatory step for SVHCs that can lead to authorisation requirements for continued use. Compliance teams tracking SVHC lifecycle management should monitor this recommendation and any subsequent Commission action affecting Annex XIV listing. The ECHA recommendations page provides the official listing of recommendation rounds and status information.
On 5 November 2025, ECHA updated the REACH SVHC Candidate List by adding 1,1'-(ethane-1,2-diyl)bis[pentabromobenzene] (DBDPE) (EC 284-366-9; CAS 84852-53-9), identified as vPvB under REACH Article 57(e). The Candidate List total increased to 251 entries. Compliance teams should evaluate product/article portfolios for the presence of DBDPE and address Candidate List-triggered obligations (e.g., Article 33 communication for SVHCs in articles above 0.1% w/w and ECHA notification duties for SVHCs in articles as applicable), consistent with ECHA’s standard SVHC Candidate List messaging.
ECHA published a draft mapping of PFAS uses intended to support the upcoming consultation related to the SEAC draft opinion in the ongoing EU-wide REACH restriction process for PFAS. Compliance teams should monitor this mapping because it can influence how use categories are framed in the restriction evaluation and can affect sector-specific impact assessment and future substitution/justification planning for PFAS uses.